Skip to main content

FRED ALGER MANAGEMENT, LLC

Position in ACAD — Acadia Pharmaceuticals Inc

CIK 3520 NEW YORK, NY

Position in ACAD

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$28,429,380
-$13,237,203 QoQ
Shares Held
1,277,151
-18.1% QoQ
Ownership
0.746%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 83.25037524928533.ToString("F0")% Shared 0.ToString("F0")% None 16.749624750714677.ToString("F0")%

Common Shares in ACAD Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

FRED ALGER MANAGEMENT, LLC holds $649,233,872 across 51 Biotechnology names. ACAD ranks #6 (4.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 ACAD
Acadia Pharmaceuticals Inc
This page
1,277,151 $28,429,380

All Filings in ACAD

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $28,429,380 1,277,151
2025-12-31 $41,666,583 1,559,962
2025-09-30 $33,440,525 1,567,035
2025-06-30 $51,497,424 2,387,456
2025-03-31 $46,006,842 2,769,828
2024-12-31 $49,818,945 2,714,929
2024-09-30 $49,006,662 3,186,389
2024-06-30 $43,947,133 2,704,439
2024-03-31 $41,742,358 2,257,564
2023-12-31 $99,464,824 3,176,775
2023-09-30 $64,789,121 3,108,883
2023-06-30 $53,673,505 2,241,065
2023-03-31 $32,476,280 1,725,626
2022-12-31 $23,285,451 1,462,654
2022-09-30 $25,142,604 1,536,834
2022-06-30 $22,850,710 1,621,768
2022-03-31 $41,559,993 1,715,937
2021-12-31 $42,942,169 1,839,853
2021-09-30 $36,092,831 2,172,958
2021-06-30 $68,374,121 2,803,367
2021-03-31 $71,885,559 2,786,262
2020-12-31 $127,867,873 2,391,842
2020-09-30 $85,723,605 2,078,148
2020-06-30 $58,809,038 1,213,308
2020-03-31 $47,648,367 1,127,772